Table 3 Comparison of nitric oxide (NO) and asymmetric dimethylarginine (ADMA) levels of migraine subgroups
From: Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine
Migraine during attack (n = 25) | Interictal period (n = 24) | p | |
|---|---|---|---|
NO (μmol/L) | 35.3 ± 6.4 | 35.8 ± 8.5 | N.S. |
ADMA (μmol/L) | 0.407 ± 0.025 | 0.410 ± 0.031 | N.S. |
Migraine with aura (n = 22) | Without aura (n = 37) | P | |
NO (μmol/L) | 35.0 ± 6.5 | 35.9 ± 8.4 | N.S. |
ADMA (μmol/L) | 0.406 ± 0.017 | 0.410 ± 0.033 | N.S. |